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Abstract
Background: This paper examines how the cost-effectiveness of IRS varies depending on the
severity of transmission and level of programme coverage and how efficiency could be improved
by incorporating climate information into decision making for malaria control programmes as part
of an integrated Malaria Early Warning and Response System (MEWS).
Methods: A climate driven model of malaria transmission was used to simulate cost-effectiveness
of alternative IRS coverage levels over six epidemic and non-epidemic years. Decision rules for a
potential MEWS system that triggers different IRS coverage are described. The average and
marginal cost per case averted with baseline IRS coverage (24%) and under varying IRS coverage
levels (50%, 75% and 100%) were calculated.
Results: Average cost-effectiveness of 24% coverage varies dramatically between years, from
US$108 per case prevented in low transmission to US$0.42 in epidemic years. Similarly for higher
coverage (24–100%) cost per case prevented is far higher in low than high transmission years
($108–$267 to $0.88–$2.26).
Discussion: Efficiency and health benefit gains could be achieved by implementing MEWS that
provides timely, accurate information. Evidence from southern Africa, (especially Botswana)
supports this.
Conclusion: Advance knowledge of transmission severity can help managers make coverage
decisions which optimise resource use and exploit efficiency gains if a fully integrated MEWS is in
place alongside a health system with sufficient flexibility to modify control plans in response to
information. More countries and programmes should be supported to use the best available
evidence and science to integrate climate informed MEWS into decision making within malaria
control programmes.
Background
Quantifying the burden of malaria remains a major chal-
lenge as many infections may be asymptomatic, inade-
quate diagnosis and reporting and the fact that a majority
of febrile cases do not reach the formal health system
make estimation imprecise. Recent estimates espouse the
figures of 300–600 million infections and 1–3 million
deaths per year [1]. Less contentious is the fact that Africa
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bears the brunt of the malaria burden, with estimates sug-
gesting greater than 60% of the worlds clinical cases and
more than 90% of the worlds malaria deaths [2].
Africa's population is estimated to pass 1 billion people
by 2010 [3]. The current goal of the Global Malaria Pro-
gramme and the Roll Back Malaria Partnership is to "halve
the malaria burden by 2010" by focussing on treatment,
prevention and epidemic response[4]. Africa is not yet on
track to achieve this goal [5].
It is estimated that 615 million Africans live in endemic
regions, where those most at risk are children under 5 and
pregnant women, non-pregnant women and adult males
are protected, to varying degrees, by acquired immunity.
There are a further estimated 125 million people at risk
from epidemic malaria in sub Saharan Africa [6]. By defi-
nition in epidemic prone areas, transmission intensity
(usually indicated by the entomological inoculation rate,
or EIR) is insufficient for the population to develop
acquired immunity; therefore this entire population of
125 million people is at risk of severe morbidity and mor-
tality from malaria [7]. People living in malaria endemic
regions acquire immunity to malaria through natural
exposure to malaria parasites. This naturally acquired
immunity is protective against parasites and clinical dis-
ease but it only results after continued exposure from mul-
tiple infections over time. The transmission intensity
influences the course of development of clinical and par-
asitic immunity. In areas of intense transmission, young
children bear the burden of malaria, but as they grow
older they build up acquired immunity. In areas of low
endemicity both children and adults suffer disease and
high parasitaemia because exposure is less [8].
Pregnant women are more susceptible than non-pregnant
women to malaria because of a combination of immuno-
logical and hormonal changes associated with pregnancy,
and with the unique ability of certain variants of infected
erythrocyts to sequester in the placenta [9]. Proportionally
more pregnant women are at risk in epidemic settings
because in high transmission areas, multi-gravidae are
partially protected from adverse effects and only primi-
gravidae are indisputably at greater risk of infection than
non-pregnant women [10]. The clinical features of
malaria infection during pregnancy also vary by epidemi-
ologic setting. Severe disease (such as cerebral malaria and
respiratory distress syndrome) is a more common charac-
teristic in low and unstable malaria transmission areas,
whereas pregnant women in high transmission areas
rarely experience cerebral malaria but instead have more
frequent exposure to malaria leading to severe anaemia
[11]. In all areas, malaria in pregnancy is responsible for
low birth weight (LBW) deliveries [12].
In epidemic prone areas malaria control interventions
aim to protect the entire population for mortality,
whereas in endemic areas, interventions only afford pro-
tection to vulnerable sub-population groups such as
young children and pregnant women from mortality and
the general population from morbidity.
Approximately 20% of sub-Saharan Africa's population,
under five's and pregnant women, living in endemic
malaria areas are subject to malaria as a major life threat-
ening disease (Africa Malaria Report: WHO-AFRO 2006).
This is roughly equivalent in numbers to the estimated
125 million people at risk of severe disease and death
from malaria epidemics [7]. However, although the pop-
ulation at risk is roughly equivalent in endemic and non
endemic areas, in the former the risk is constant from one
year to the next whereas in epidemic prone areas the risk
may only be high in certain years. Hence the temporal ele-
ment of risk needs to be considered. Thus endemic and
epidemic malaria require different approaches to control
and prevention. Endemic malaria requires ongoing meas-
ures whereas successful control of epidemic malaria relies
on measures being applied in the right place at the right
time, this is even more important when resources are
scarce [13].
The global malaria strategy calls for sustained commit-
ment to address malaria epidemics [14], but there has
been less focus on epidemics relative to other strategic
areas of intervention such as scaling up of ITN use.
Recently there has been a renewed emphasis on malaria
vector control with indoor residual spraying (IRS), espe-
cially under the US Government's Presidential Malaria
Initiative (PMI). PMI is supporting enhanced malaria con-
trol in fifteen African countries, many of which are or will
be using IRS as part of a package of malaria control. A
growing body of evidence shows that IRS and ITNs (and
more recently LLINs) are highly cost-effective malaria con-
trol interventions [15,16]. More recently focus has shifted
towards examining the relative cost-effectiveness of these
two interventions in comparison to each other [17]. How-
ever, there is still a dearth of evidence on the cost-effective-
ness of malaria control interventions in epidemic prone
areas [6] and economic evaluations of interventions in
epidemic or seasonal transmission areas commonly fail to
account for key differences in assessing malaria control
interventions in epidemic as opposed to endemic settings.
A previous paper has shown how the effectiveness of IRS
(in terms of cases prevented) varies according to the mag-
nitude of transmission each year, as well as the timing of
IRS in relation to the transmission season [18].
This paper examines how the cost-effectiveness of IRS var-
ies depending on the severity of transmission and level ofMalaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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coverage. It also investigates how efficiency could be
improved by incorporating climate information into the
decision making process of malaria control programmes
as part of an integrated Malaria Early Warning and
Response System (MEWS) [19]. Put another way this
study aims to show how more health impact can be
obtained through use of the same or similar resources if
climate information was used to inform programme deci-
sions.
Firstly, available evidence on the cost and cost-effective-
ness of IRS in sub-Saharan Africa is reviewed to establish
what is already known about the key drivers of cost and
cost-effectiveness of IRS and highlight limitations of exist-
ing studies. Secondly, novel cost data on an operational
IRS programme from Zimbabwe is presented. Thirdly,
investigation is made into how cost-effectiveness and
marginal cost-effectiveness of IRS varies depending on
severity of transmission and simulated level of IRS pro-
gramme coverage. Finally, a discussion focuses on how
the cost-effectiveness of IRS and other malaria control
interventions can be improved through the incorporation
of climate information into malaria control programming
decisions.
Cost of indoor residual spraying
Table 1 summarizes the results of studies on the cost (and
cost-effectiveness) of IRS in sub-Saharan Africa. Only four
published studies were located on the cost-effectiveness of
actual IRS programmes in sub-Saharan Africa:
1. A comparison of IRS and ITNs in Tanzania [20]
2. A comparison of IRS and ITNs in highland Kenya
[21,22]f
3. A comparison of IRS and ITNs in KwaZulu-Natal, South
Africa [23]
4. An evaluation of IRS in Mozambique [24]
Further studies of relevance are:
5. A reanalysis of the South African KwaZulu-Natal study
[17]
6. A reanalysis of the Mozambique study [17]
7. A comprehensive modelling study comparing the cost-
effectiveness of a variety of malaria control interventions
[25,26].
The studies show that the unit cost per year of IRS is
between $0.88 (study 2 highland Kenya) and $30.35
(study 5 reanalysis of Kwazulu-Natal). However, there are
some methodological and real differences which explain
these differentials in costs. For example some studies only
valued the protection afforded to children whereas others
included the whole population. Costing methodology
may also have differed (for example what is included or
excluded). The type and price of insecticide used will also
affect cost (and effectiveness) of programmes. Other fac-
tors which may cause variation in programme cost are the
programme structure, population density, geographical
area and topography of where the spray programme took
place, as well as the scale and efficiency of the programme.
See Additional file 1 for a more detailed discussion of
these comparability issues.
Cost-effectiveness
Table 1 shows the cost-effectiveness of IRS programmes
for the 7 studies (where available). The studies are not
consistent in the effectiveness indicator used. Studies 2
and 4 provide a cost per infection case prevented ($9 and
$29 respectively). Study 3 is a marginal cost analysis com-
paring ITNs to IRS and as such does not give the cost-effec-
tiveness of IRS alone. Study 5 and 6 carried out additional
analysis on study 3 and 4 to come up with a cost per death
and Disability Adjusted Life Year (DALY, combines the
morbidity and mortality indicators into a single unit)
averted. In the Kwazulu-Natal reanalysis (study 5) the cost
per death averted was $596 compared to $897 in Mozam-
bique (study 6). The cost per DALY averted in these two
studies was similar at $23 and $27 respectively, a similar
range to the modelling study (7) which estimated a cost
per DALY averted of between $12–22 for a single spray
round and between $24–44 for two spray rounds.
That these results are fairly consistent (where comparable)
in terms of cost per infection case, death and DALY
averted, is encouraging. It is also important to point out
that the cost-effectiveness of IRS is attractive based on
these results [27].
A critical factor overlooked by all the existing evaluations
of IRS reviewed here is the climate related inter-annual or
spatial variation in malaria transmission. Epidemics are
often the health manifestation of weather or climate
anomalies (which have resulted in extensive flooding or
an extended transmission season) which directly increase
the hazard to the population (in this case transmission
intensity)
The level of risk of any population may be understood as
a function of the hazard and the population's vulnerabil-
ity to that hazard (in this case population immunity and
socio-economic factors).
In epidemic areas IRS protects the population against a
hazard which may vary from year to year according to theMalaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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climate. Assessments of the impact of IRS and other anti-
malaria interventions which do not take into account the
climate risk may introduce serious bias into the results
[28]
Studies on the impact of IRS which do not control for cli-
mate variation cannot be sure if it is the IRS, or for exam-
ple drought, which is responsible for reductions in
malaria incidence; in many parts of the world droughts
are a good predictor of control 'success'!
Table 1: Economic cost (in 2000US$*) and CE of IRS in sub-Saharan Africa
Study (number) and Location
[costs reported in original study]
Intervention description and 
scale
Unit Cost per year†
(rounded to nearest cent)
Cost-effectiveness
(rounded to nearest $)
Study (1) Tanzania
[20]
￿ IRS one round per year
￿ Lambda chyhalothrin (Icon)
￿ 1000 people covered
$2.45 per person protected No Data
Study (2)
Highland Kenya
[2000 $]
￿ IRS one round per year
￿ Lambda cyhalothrin (Icon)
￿ 1752 people covered
$0.88 per person protected
[22]
$9 per infection case prevented
[21]
Study (3)
KwaZulu Natal, S Africa [23]
[1999 Rand and $]
￿ IRS one round per year
￿ Deltamethrin
￿ 26,703 people covered
$4.93 per person protected No Data
Study (4)
LSDI, Mozambique
[2000 $]
￿ IRS two rounds per year
￿ FICAM and Propoxur
￿ 251,918 people covered
Zone 1: 1 round FICAM, 1 round 
Propoxur (71047 people)
Zone 1A: 2 rounds FICAM 
(180871 people)
$4.82 per person protected
Zone 1:
$3.48 per person protected
Zone 1A:
$2.16 per person protected
$28 per clinical case averted
$29 per infection case prevented
Study (5)
Reanalysis of Kwa-Zulu Natal, 
South Africa
[17]
[$2005]
￿ IRS one round per year
￿ Deltamethrin
￿ 26,703 people covered
$4.27 per person protected $596 per death averted
$23 per DALY averted‡
$30.35 cost per under five 
protected
$5518 per under five death 
averted
$167 per under five DALY averted
Study (6)
Reanalysis of LSDI, Mozambique**
[17]
[$2005]
￿ IRS two rounds per year
￿ FICAM and Propoxur
￿ 251,918 people covered
$4.94 per person protected $897 per death averted
$27 per DALY averted
$27.40 per under five protected $4981 per death averted
$151 per DALY averted
￿ IRS one round per year
￿ Lambda cyhalothrin (Icon)
$4.34–7.67 per under five 
protected
[26]
$12–22 per under five DALY 
averted [25]
￿ IRS two rounds per year
￿ Lambda cyhalothrin (Icon)
$8.69–15.34 per under five 
protected
[26]
$24–44 per under five DALY 
averted [25]
*Converted from original source by author where necessary using US government GDP price deflator: U.S. Bureau of Economic Analysis (BEA) 
(2008). U.S. Implicit Price Deflators for Gross Domestic Product [On-line]. Available: http://www.bea.gov
†Unit cost per year = Total annual costs divided by population protected by intervention
‡Examines only child deaths but allocates costs to child DALYs averted based on proportion of children in populationMalaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
Page 5 of 10
(page number not for citation purposes)
Of the empirical studies considered here, 2, 3 and 4 were
carried out in areas of seasonal and epidemic prone
malaria transmission, yet none of them consider the
impact of climate variability and therefore potentially
overestimate or underestimate the benefits of IRS because
of spatial or temporal variations between the intervention
site and/or year and the control.
Methods
The economic costs of the IRS programme in Hwange Dis-
trict, of Zimbabwe were captured for a twelve month
period aligned with the 1998/99 malaria transmission
season using standard economic costing methodology
[29]. Full details of the study area, IRS programme, cost-
ing methods and results are given in Additional file 2.
Using the same model presented in a previous paper [30],
the unit cost data was combined with estimates of the
effectiveness of IRS over a six year period to examine how
the average and marginal cost-effectiveness of a pro-
gramme varies depending on (i) the level of spray cover-
age achieved and (ii) the severity of transmission. The
model was then used to simulate the number of cases that
would occur given five alternative levels of spray coverage,
effective from January each year. The coverage levels
examined were 0%, 24%, 50%, 75% and 100%.
24% coverage is the actual level of coverage achieved over-
all in Hwange, District this is because the IRS programme
targeted administrative units smaller than districts,
achieving high levels of coverage (80–95%) in these sub-
units but an average coverage level of 24% throughout the
District. Hence what our coverage levels refer to is the per-
centage of the district targeted for IRS with the implicit
assumption that the level of coverage achieved is suffi-
ciently high (> 85%) for the IRS to achieve impact.
For each year and level of spray coverage the total cost of
the spray programme was calculated, the number of cases
prevented and the average cost per case prevented com-
pared to the no coverage (0%) scenario. Next the marginal
cost per case prevented of additional coverage levels com-
pared to the baseline (24%) scenario was calculated. Full
details and results of simulations on cases and cases pre-
vented can be found in [30].
In order to examine the impact of severity of transmission,
each year was categorized in our dataset as low, medium,
high or epidemic depending on the number of simulated
cases with no intervention) (0–50,000; 50,001–100,000;
100,001–150,000 and 150,001–200,000 respectively) as
shown in columns 1 – 3 of Table 2.
Next the potential efficiency implications of a MEWS
which would allow programme managers to choose the
level of IRS programme coverage in advance based on
information about the likely severity of the forthcoming
malaria transmission season was examined. It was
assumed that the forecast would influence decision mak-
ing regarding IRS programme coverage, as shown in col-
umns 2 and 4 of Table 2, as part of a MEWS. This was
labelled the "implied level of coverage", i.e. the level of
coverage that the MEWS indicated would be appropriate
given predicted transmission potential each year. Note
that there are no years where 0% coverage would be rec-
ommended and alternatives are being compared to the
baseline level of coverage (24%) hence the key variable of
interest here is marginal (as opposed to average) cost-
effectiveness.
Results
IRS programme costs
The costs of the Hwange District IRS programme are sum-
marized in Table 3. The total cost was US$47,000 with
chemical costs forming the vast majority (81%) of pro-
gramme costs followed by equipment costs (11%) and
labour costs (4%).
The number of structures sprayed in Hwange district was
24,236 and the estimated population covered was 39,416
Table 2: Transmission season categories and implied IRS coverage levels
12 3 4
Cases occurring with no intervention Severity of transmission (actual or predicted) Years in this category Implied IRS Coverage Level
0–50,00 Low transmission 1993, 1994 24%
50,001–100,000 Medium transmission 1995 50%
100,001–150,000 High transmission 1997
1998
75%
150,001–200,000 Epidemic 1996 100%Malaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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(Source: Hwange District Environmental Health Office
and Matabeleland North Provincial Environmental
Health Office). The cost per person protected by the spray
programme was therefore $1.01 in 2000 US$.
This result is comparable with those in Table 1. although
at the low end. One reason for this could be the lack of
inclusion of all central level costs however it is also likely
to be due to the fact that this was an operational pro-
gramme being carried out by the Government of Zimba-
bwe with no external international assistance which can
increase programme costs. An operational programme is
also far from the "optimal" programme which would be
costed under a comprehensive modelling approach (e.g.
study 7) which seeks to include all required inputs. For
example, in the Hwange programme, very little resources
were devoted to supervision and community sensitisa-
tion, and none to monitoring and evaluation.
Average cost-effectiveness
The average cost-effectiveness (Table 4) of the baseline
level of coverage (compared to 0% coverage) varies dra-
matically between years, from US$108 per case prevented
in 1993 (a low transmission year where IRS can poten-
tially prevent relatively fewer cases) to US$0.42 in 1996,
the epidemic year where the potential gains from effective
high coverage IRS are far higher. The results also show the
variation in range of average cost-effectiveness of different
coverage levels depending on severity of transmission. In
the lowest transmission year (1993) the range for 24%–
100% coverage is between $108–$267 per case prevented,
whereas in the epidemic year (1996) the range is lower
and narrower at between $0.88–$2.26 per case prevented.
Overall the results show that it is more cost-effective to
intervene in high transmission years and that even at
100% coverage the cost per case prevented is still below
$10 in all but the low transmission years (1993 and
1994).
Marginal cost-effectiveness
The marginal cost-effectiveness results show how much it
would cost to prevent additional cases by increasing the
IRS coverage level from the baseline (24%) to 50%, 75%
or 100% (Table 5). In medium, high or epidemic trans-
mission years the marginal cost per case prevented is never
more than $5.19 even up to coverage levels of 100%.
However, in 1993 (low transmission) the marginal cost-
effectiveness of 100% coverage was approximately $500
per case prevented. This illustrates that relative to other
years, increased levels of spray coverage in low transmis-
sion years are not an efficient use of resources.
Potential efficiency gains
Next the efficiency implications of an IRS programme
where the implied level of coverage as implied by the
MEWS forecast was sprayed each year were examined. In
1993 and 1994 (low transmission years) the system
would dictate 24% (baseline) coverage. At these coverage
levels the average and marginal cost per case prevented
would be $108.12 and $4.23 respectively (Table 6). This
Table 3: Cost of Hwange District IRS programme (US$)
Cost Item US$ % of Total Cost
Chemicals 38023 81
Labour (excluding Community Education) 1947 4
Transport 1459 3
Equipment 5118 11
Community Education 518 1
TOTAL 47065 100
Table 4: Average cost per case prevented (compared to 0%) of 
alternative coverage levels (US$)
IRS coverage level
Year 24% (Baseline) 50% 75% 100%
1993 108.12 153.99 206.84 267.15
1994 4.23 6.01 8.07 10.41
1995 0.87 1.33 1.83 2.37
1996 0.42 0.57 0.72 0.91
1997 0.63 0.97 1.31 1.69
1998 0.88 1.36 1.78 2.26
Table 5: Marginal Cost per Case prevented (compared to 
baseline, 24%) of alternative coverage levels
IRS coverage level
Year 50% 75% 100%
1993 253.13 362.66 498.86
1994 9.84 14.05 19.29
1995 2.60 3.77 5.19
1996 0.85 1.08 1.42
1997 1.94 2.67 3.60
1998 2.73 3.42 4.49Malaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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system would ensure that as discussed above, relatively
inefficient high levels of coverage would be avoided in
low transmission years. In the epidemic transmission year
(1996) 100% spray coverage would still only cost an aver-
age and marginal cost of $0.91 and $1.42 respectively,
clearly if the programme is affordable these ratios are
highly attractive.
Study limitations
The unit cost estimate of $1.01 per person protected with
IRS was used for all years to avoid introducing additional
variation into the analysis that would stop us from observ-
ing the impact of changes in the two variables of interest
(severity and coverage). A key limitation of using a fixed
unit cost per person protected is that it assumes constant
returns to scale with spray programme coverage. This is
unlikely to reflect the reality where there are likely to be
economies of scale up to point where diseconomies set in
and the costs of reaching the last few individuals increase.
Neither these data nor the literature gives any clear indica-
tion regarding the impact of scale on unit cost of spray
programmes. The impact of this on the results in this
study is likely to be constrained because in all IRS pro-
grammes the cost of the insecticide is a large proportion of
total costs and hence the ability to achieve significant
economies of scale is limited by the relatively fixed unit
cost of insecticides. In addition, the coverage level of
100% used in this analysis is used for convenience only,
in reality programme coverage of 100% is not operation-
ally achievable and so resources would not be used to
reach the last, most expensive person/households.
Using a system where increased levels of coverage are trig-
gered by a forecast of epidemic risk is likely to cost more,
especially if the cost of increased coverage is not fully off-
set by reduced coverage in low transmission years. How-
ever, this analysis has shown that the value of that
protection in terms of health benefit (cases prevented) is
greater in high transmission years. This additional
expense must therefore be offset against the additional
health benefits and financial savings made through
greater efficiency of interventions in high transmission
and epidemic years. This analysis has examined the cost
from the provider perspective but has not included any
potential cost savings to the health system of preventing
malaria cases. Preventing cases occurring will save on drug
consumption and possibly staff time within the health
system, subject to accurate malaria diagnosis and flexibil-
ity in the system. There may also be savings in out of
pocket expenditure and reduced opportunity cost from
households associated with preventing cases.
In the current analysis, there are four possible levels of
transmission (low, medium, high and epidemic) detected
by the MEWS, that trigger a decision to deliver four alter-
native coverage levels. In reality systems may not be this
sophisticated, but this has just been for the purposes of
the analysis to obtain more data points. In reality a pro-
gramme may choose only to have three or even two differ-
ent coverage level triggers and decisions to simplify the
system, but there are still potential efficiency gains to be
made. For example in Botswana, where case surveillance
is used as part of a MEWS there are three case thresholds
which have distinct predetermined actions; deploying
additional medical staff to the area, deploying mobile
treatment teams and declaring a disaster to trigger disaster
response plan [13]. Decisions also need a geographical
element and the results of this study would equally apply
to this element. For example, a decision to target a rela-
tively high transmission area would result in a more effi-
cient use of resources than spraying all districts with the
same level of coverage regardless of transmission inten-
sity.
The exact nature of the decision matrix (as illustrated in
Table 2) would have to be developed by individual pro-
grammes depending on a number of factors such as avail-
able resources, country priorities, epidemiology and
Table 6: Average and Marginal Cost-effectiveness of MEWS informed decisions
Year MEWS prediction Implied IRS Coverage Level Average cost-effectiveness at implied 
coverage level ($)
Marginal cost-effectiveness at implied 
coverage level ($)
1993 Low 24% 108.12 -
1994 Low 24% 4.23 -
1995 Medium 50% 1.33 3.77
1996 Epidemic 100% 0.91 1.42
1997 High 75% 1.31 2.67
1998 High 75% 1.36 2.73Malaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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coverage of health services. In the example presented
above it might be appropriate to have not sprayed at all in
1993 since the number of cases occurring with no inter-
vention and therefore the potential health benefit of any
level of IRS coverage would be very low, this is reflected in
the high average cost per case prevented at 24% coverage
of $108.12. A decision not to spray at all however, would
have to be balanced by a high degree of certainty that the
forecast was correct.
Discussion
For this type of system to be of practical use (and reap the
hypothetical efficiency and health benefit gains presented
in this paper) there are two interrelated key factors which
need to be considered. The first is the accuracy (ability to
predict malaria season severity) of the information and
the second is the timeliness of the information, especially
in relation to health services capacity to respond. The
present analysis assumes that the MEWS is accurate (does
not predict false epidemics or miss real epidemics) and
that the information is available sufficiently early for pro-
gramme managers to use it as a basis to make IRS pro-
gramme coverage decisions. WHO has, since 2002,
promoted a framework for malaria early warning in which
four components are operating [31]. The components are:
1) vulnerability monitoring; 2) seasonal climate forecast-
ing; 3) environmental monitoring and 4) sentinel case
surveillance; each informing elements of control plan-
ning, preparedness and response.
Vulnerability monitoring of factors such as HIV AIDS inci-
dence, drug resistance and food insecurity helps keep
track of factors which increase the severity of disease out-
come should an epidemic occur. Seasonal climate fore-
casts provide advance warning of the potential for malaria
epidemics to occur. Environmental monitoring, e.g. of
rainfall can be used to monitor the accuracy seasonal cli-
mate forecasts, yet it still offers some lead time to inform
programme decisions. Sentinel case surveillance data is of
paramount importance in early detection of epidemics
but may come too late to trigger a full preventive
response. The WHO framework to malaria early warning
has been adopted in a number of epidemic prone coun-
tries in Southern Africa [32]. In Botswana an analysis of
national confirmed malaria incidence over 20 years
revealed that year to year variation in rainfall could
account for the year to year variations in incidence once
long term vulnerability changes had been taken into
account [33].
Furthermore seasonal climate forecasts issued in Novem-
ber, four to five months prior to the peak malaria season,
were found to accurately predict five low malaria trans-
mission years and four out of five high transmission years
in Botswana [34].
Of the southern African countries (Botswana, Madagascar,
Mozambique, Namibia, South Africa, Swaziland and Zim-
babwe) involved in these efforts, Botswana has perhaps
the most advanced and well resourced system. There is
evidence that in a recent wet year following several dry
years (2005–06 malaria season), cases were ten times
lower in Botswana than in a previous year with similar
conditions (1996–97). In Zimbabwe, where political and
economic constraints have hampered efforts to imple-
ment MEWS and malaria control more generally, cases
were down by half. MEWS may have contributed to these
successes but changes in other factors (e.g. availability of
drugs and increased ITN use) will also have had an effect
[13].
Conclusion
For practical reasons, programme managers are not likely
to be interested in such detailed analysis of average and
marginal cost per case prevented. However, on a broad
operational level the results clearly show that compared to
spraying the same level of coverage each year, programme
managers could ensure a more effective and efficient use
of resources by using information on likely transmission
severity to inform IRS programme coverage. Accurate
advance knowledge of the severity of the transmission sea-
son could help managers make coverage decisions which
optimize resource use and exploit efficiency gains
afforded by the greater effectiveness of IRS in high trans-
mission seasons. They can also avoid using resources
unnecessarily in a low transmission year.
The efficiency gains examined in this paper could only be
realized if a fully integrated MEWS was in place within a
health system with sufficient flexibility to modify control
plans in response to forecasts. This is the case in Botswana
where it is likely that some efficiency gains and greater
health benefits are being realized, if not actually quanti-
fied. Increasing the use of MEWS and flexible response
systems further, especially in relation to IRS programme
planning and decision making, has the potential to ensure
malaria control programme decisions are more efficient
and critically have greater health impact.
Increased resources are available for both malaria control
and IRS in particular. However, resources are still scarce in
relation to the burden of malaria. There is thus a need to
ensure resources are used as efficiently as possible to gen-
erate maximum health benefit. We have the scientific
understanding to predict malaria transmission using cli-
mate and other indicators [34]. There is also increasing
evidence and examples of the use of climate based early
warning systems being used as a decision making tool in
malaria control programmes [13,32]. More countries and
programmes should be supported to use the best available
evidence and scientific know how to integrate climateMalaria Journal 2008, 7:263 http://www.malariajournal.com/content/7/1/263
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informed MEWS into decision making within malaria
control programmes. The current focus on climate change
adaptation and improved management of climate sensi-
tive risk in national development sectors offers opportuni-
ties for Ministries of Health to request greater engagement
with their national counterparts in climate and weather
services. There are currently only a few countries pioneer-
ing this approach, however national and international
development donors are seeking to invest strongly in
improving climate risk management in coming years
[13,35]
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